Metformin as an adjuvant option for systemic treatment of breast cancer
The modification of the used and development of new treatment regimens significantly improved the overall, recurrence-free survival and quality of life of patients with malignant oncological diseases. Recently, drugs used in non-oncological pathology have been introduced into cancer treatment regime...
Saved in:
Main Authors: | D.I. Avierin, V.F. Zavizion |
---|---|
Format: | Article |
Language: | English |
Published: |
Dnipro State Medical University
2023-12-01
|
Series: | Medičnì Perspektivi |
Subjects: | |
Online Access: | https://journals.uran.ua/index.php/2307-0404/article/view/294154 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of artificial intelligence in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer
by: Wei Wei, et al.
Published: (2024-09-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01) -
Metformin increases mammographic breast density: a randomized controlled trial
by: Sadaf Alipour, et al.
Published: (2025-01-01)